SENS — Senseonics Holdings, Inc.
$7.51+1.49%
Last close: · regular session
Last 60 sessions
SENS closed at $7.51 (+1.49%) on Oct 23, 2026. Active shelf registration (S-3, Aug 2025). Float: 37.0M shares. Latest SEC filing: 10-Q on Aug 6, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for SENS in the TickerWise workspace.
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ
- Employees: 117
- Website: https://www.senseonics.com
Latest SEC filings for SENS
Latest SENS news
- Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component Read article
- Senseonics: Eversense 365 Adoption Has To Earn The Valuation Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.